Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Aug 7;46(31):9058-67.
doi: 10.1021/bi700688x. Epub 2007 Jul 14.

Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase

Affiliations

Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase

Xinxin Yang et al. Biochemistry. .

Abstract

New approaches are required to combat Mycobacterium tuberculosis (Mtb), especially the multi-drug resistant and extremely drug resistant organisms (MDR-TB and XDR-TB). There are many reports that mycobacteria oxidize 3beta-hydroxysterols to 3-ketosteroids, but the enzymes responsible for this activity have not been identified in mycobacterial species. In this work, the Rv1106c gene that is annotated as a 3beta-hydroxysteroid dehydrogenase in Mtb has been cloned and heterologously expressed. The purified enzyme was kinetically characterized and found to have a pH optimum between 8.5 and 9.5. The enzyme, which is a member of the short chain dehydrogenase superfamily, uses NAD+ as a cofactor and oxidizes cholesterol, pregnenolone, and dehydroepiandrosterone to their respective 3-keto-4-ene products. The enzyme forms a ternary complex with NAD+ binding before the sterol. The enzyme shows no substrate preference for dehydroepiandrosterone versus pregnenolone with second-order rate constants (kcat/Km) of 3.2 +/- 0.4 and 3.9 +/- 0.9 microM-1 min-1, respectively, at pH 8.5, 150 mM NaCl, 30 mM MgCl2, and saturating NAD+. Trilostane is a competitive inhibitor of dehydroepiandrosterone with a Ki of 197 +/- 8 microM. The expression of the 3beta-hydroxysteroid dehydrogenase in Mtb is intracellular. Disruption of the 3beta-hydroxysteroid dehydrogenase gene in Mtb abrogates mycobacterial cholesterol oxidation activity. These data are consistent with the Rv1106c gene being the one responsible for 3beta-hydroxysterol oxidation in Mtb.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Unrooted phylogenetic tree for 3β-hydroxysteroid dehydrogenase encoded by Rv1106c and related proteins. The values are relative evolutionary distance. The tree was generated using a ClustalW 1.82 alignment and CLC Free Workbench 3. Proteins are identified by species, enzyme, and Uniprot ID.
Figure 2
Figure 2
pH dependence of the reaction catalyzed by rH63BHSD with DHEA as the varied substrate. Conditions: 2.8 mM NAD+, 100 mM TAPS hydrochloride buffer, 150 mM NaCl, 30 mM MgCl2, pH 8.5, 30 °C. A, pH dependence of kcat. B, pH dependence of kca/Km. The curves are fits to eq. (7). The data shown are the average of three independent experiments, and the errors are the standard deviation of measurement.
Figure 2
Figure 2
pH dependence of the reaction catalyzed by rH63BHSD with DHEA as the varied substrate. Conditions: 2.8 mM NAD+, 100 mM TAPS hydrochloride buffer, 150 mM NaCl, 30 mM MgCl2, pH 8.5, 30 °C. A, pH dependence of kcat. B, pH dependence of kca/Km. The curves are fits to eq. (7). The data shown are the average of three independent experiments, and the errors are the standard deviation of measurement.
Figure 3
Figure 3
Cation dependence of rH63BHSD activity. A, Specific activity in the presence of assorted cations or EDTA. Conditions: 150 μM DHEA, 3.5 mM NAD+, 100 mM triethanolamine hydrochloride buffer, pH 8.5, 30 °C. B, Specific activity as a function of NaCl concentration. Conditions: 150 μM DHEA, 2.8 mM NAD+, 100 mM TAPS hydrochloride buffer, pH 8.5, 150 mM NaCl, 30 °C. C, Specific activity in the presence of 150 mM NaCl and assorted cations or EDTA. Conditions: 150 μM DHEA, 2.8 mM NAD+, 100 mM TAPS hydrochloride buffer, pH 8.5, 150 mM NaCl, 30 °C. The data shown are the average of three independent experiments, and the errors are the standard deviation of measurement.
Figure 3
Figure 3
Cation dependence of rH63BHSD activity. A, Specific activity in the presence of assorted cations or EDTA. Conditions: 150 μM DHEA, 3.5 mM NAD+, 100 mM triethanolamine hydrochloride buffer, pH 8.5, 30 °C. B, Specific activity as a function of NaCl concentration. Conditions: 150 μM DHEA, 2.8 mM NAD+, 100 mM TAPS hydrochloride buffer, pH 8.5, 150 mM NaCl, 30 °C. C, Specific activity in the presence of 150 mM NaCl and assorted cations or EDTA. Conditions: 150 μM DHEA, 2.8 mM NAD+, 100 mM TAPS hydrochloride buffer, pH 8.5, 150 mM NaCl, 30 °C. The data shown are the average of three independent experiments, and the errors are the standard deviation of measurement.
Figure 3
Figure 3
Cation dependence of rH63BHSD activity. A, Specific activity in the presence of assorted cations or EDTA. Conditions: 150 μM DHEA, 3.5 mM NAD+, 100 mM triethanolamine hydrochloride buffer, pH 8.5, 30 °C. B, Specific activity as a function of NaCl concentration. Conditions: 150 μM DHEA, 2.8 mM NAD+, 100 mM TAPS hydrochloride buffer, pH 8.5, 150 mM NaCl, 30 °C. C, Specific activity in the presence of 150 mM NaCl and assorted cations or EDTA. Conditions: 150 μM DHEA, 2.8 mM NAD+, 100 mM TAPS hydrochloride buffer, pH 8.5, 150 mM NaCl, 30 °C. The data shown are the average of three independent experiments, and the errors are the standard deviation of measurement.
Figure 4
Figure 4
Steady state kinetics of rHg6BHSD. A plot of initial velocity against NAD+ at fixed DHEA was fitted to equation (5). Conditions: 120 μM DHEA, 100 mM TAPS hydrochloride buffer, 150 mM NaCl, 30 mM MgCl2, pH 8.5, 30 °C. The data shown are the average of three independent experiments, and the errors are the standard deviation of measurement.
Scheme 1
Scheme 1
Reaction catalyzed by Mtb 3β-hydroxy steroid dehydrogenase (Rv1106c).

Similar articles

Cited by

References

    1. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle. 1991;72:1–6. - PubMed
    1. Raviglione MC, Snider DE, Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995;273:220–226. - PubMed
    1. Byarugaba DK. Antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24:105–110. - PubMed
    1. Mwinga A, Bernard Fourie P. Prospects for new tuberculosis treatment in Africa. Trop Med Int Health. 2004;9:827–832. - PubMed
    1. Raviglione MC, Smith IM. XDR tuberculosis-implications for global public health. N Engl J Med. 2007;356:656–659. - PubMed

Publication types

MeSH terms

LinkOut - more resources